Innovative Advances in Flu Testing
It’s about time we had some progress!
Influenza stands out as one of the most prevalent and contagious illnesses. In the United States alone, it leads to around 41 million cases, 710,000 hospitalizations, and 52,000 fatalities yearly.
Traditionally, diagnosing flu often involves swabs from the nose or throat to check for the virus’s presence. Yet, commercial testing options have only recently become available in the U.S.
However, there may soon be simpler methods. German researchers have developed a sensor that emits a thyme flavor when it detects the influenza virus. Their ultimate goal? To incorporate this sensor into a gum or lozenge format.
“Something easy to manufacture and supply is urgently required,” the researchers mentioned in a recent publication.
“These new tools could quickly identify individuals who might carry the flu. I’ve personally been affected by the need for quarantine.”
Historically, the FDA has taken a cautious approach due to concerns regarding flu test accuracy and potential user mistakes. Still, home diagnostic tests, including those for the flu, are entering the market.
The FDA granted emergency authorization for the first over-the-counter flu test, a combined Covid-19 and flu test, in 2023.
Last year, the FDA approved the Healgen Rapid Check Covid-19/Flu A&B antigen test, which was the first home test to receive approval for non-emergency use.
Researchers are particularly inspired by molecular sensors since a convenient and comprehensive flu testing method has been lacking.
They aim to create a framework for easy-to-access testing that’s simple to make, distribute, and use at the first sign of infection. They believe that moving towards detectors usable anywhere, anytime, might just solve this challenge.
As for the science behind how this works, the neuraminidase enzyme is found on influenza viruses’ surfaces.
This enzyme helps the virus spread by breaking down specific chemical bonds, allowing transmission from infected to healthy cells.
By developing synthetic molecules that mimic thymol’s interactions with neuraminidase, scientists have crafted a way for the sensor to release this distinct thyme flavor when the virus is present.
Notably, these sensors are specifically designed to react to influenza viruses, ensuring that they won’t return false positives from bacterial neuraminidases in saliva.
During testing with human saliva, the sensor was able to release thymol within 30 minutes of contact with the virus.
Moving forward, researchers are eager to begin testing sensors on flu patients both before and after illness onset, expected to start within two years.
In the interim, health experts continue to recommend the flu vaccine for everyone over the age of six months, barring a few exceptions. This shot works to train your immune system to recognize and combat the flu virus, helping to avoid illness and reduce severity.
Flu season generally peaks from December to February, as indoor gatherings become more common, enabling the virus to spread more easily in cold, dry conditions.
If you do catch the flu, it’s best to stay home to prevent infecting others.
